We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ETON market cap is 324.76M. The company's latest EPS is USD -0.0362 and P/E is -346.13.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12M | 7.03M | 7.31M | 7.97M | 9.07M |
| Operating Income | 3.88M | -548k | -1.99M | -800k | -2.94M |
| Net Income | 4.56M | -579k | -2.26M | -811k | -3.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 959k | 39k | 21.83M | 21.25M | 31.64M |
| Operating Income | -18.6M | -27.11M | -1.5M | -8.26M | -1.19M |
| Net Income | -18.32M | -27.97M | -1.96M | -9.02M | -936k |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.93M | 31.53M | 31.74M | 30.79M | 31.82M |
| Total Liabilities | 14.21M | 14.63M | 16.26M | 15.3M | 18.36M |
| Total Equity | 16.73M | 16.89M | 15.48M | 15.49M | 13.46M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.07M | 26.32M | 27.47M | 25.03M | 31.74M |
| Total Liabilities | 6.52M | 10.66M | 9.84M | 11.95M | 16.26M |
| Total Equity | 10.55M | 15.66M | 17.63M | 13.08M | 15.48M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 5.56M | 6.43M | 6.82M | -2.47M | -1.22M |
| Investing | N/A | N/A | -775k | -1.88M | -1.88M |
| Financing | -295k | -663k | -957k | -378k | -594k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.03M | -22.35M | -4.51M | 4.82M | 6.82M |
| Investing | -1.85M | -50k | -2.56M | -2.79M | -775k |
| Financing | 5.2M | 31.63M | 391k | -134k | -957k |
| Market Cap | 324.76M |
| Price to Earnings Ratio | -346.13 |
| Price to Sales Ratio | 10.23 |
| Price to Cash Ratio | 15.14 |
| Price to Book Ratio | 20.92 |
| Dividend Yield | - |
| Shares Outstanding | 25.84M |
| Average Volume (1 week) | 149.06k |
| Average Volume (1 Month) | 242.08k |
| 52 Week Change | 175.66% |
| 52 Week High | 13.98 |
| 52 Week Low | 3.03 |
| Spread (Intraday) | 6.09 (43.22%) |
| Company Name | Eton Pharmaceuticals Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.etonpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
